A Senior Medical Scientific Liaison is a field-based disease state expert responsible for supporting company's strategic and scientific objectives, by exchanging scientific information with rostered scientific leaders about an assigned product and therapeutic area (TA) through balanced discussion. Providing accurate, fair and balanced scientific exchange is a core function. The MSL's interactions with scientific leaders are organic, comprehensive peer-to-peer discussions enabling their assessment of evolving standards of care for patients and research opportunities. Scientific exchange allows the Sr. MSL to collect insights regarding gaps in understanding and data needed by the healthcare community that can be shared with the wider organization.
Being a subject matter expert who engage in non-promotional scientific exchange with Scientific Leaders or Key Decision Makers (SLs or KDMs)
Execute Field Medical Engagement Plans (as priorities) within the scope of local and global policies, local rules and regulations and aligned with the Field Medical SOP and Country Medical Affairs Plan
The Sr. MSL's primary responsibility is to engage in non-promotional peer-to-peer communication with medical/scientific information to SLs and KDMs on their roster, based on scientific exchange and services oriented towards the stakeholder's professional interests & needs.
May have an opportunity to cover multiple therapy areas or markets based on strategies.
They do this by:
Defining and maintaining a roster of Scientific Leaders and Key Decision Makers in their therapeutic area.
Interacting with identified Scientific Leaders and healthcare administrators (KDMs) by exchanging balanced medical / scientific information and by appropriately communicating these exchanges with internal colleagues.
Utilizing scientific and medical expertise to communicate scientific information in individual and group presentations.
Respond to unsolicited requests for medical, scientific, pipeline, organization product information from SLs or KDMs utilizing appropriate approved scientific materials and appropriately documenting the use of these resources.
Providing insights internally on scientific gaps, ideas and other topics gathered from Scientific exchange to inform areas of interest, clinical trial programs, development programs and company TA strategy.
Work with GMSA/GCTO to identify potential investigators for Phase 1, 2 and 3 clinical trials
Ensuring various engagement metrics (both quantitative and qualitative) are achieved.
Providing on-label medical insights and training to internal colleagues including the organization and competitor products and disease state with their therapeutic knowledge.
Attending / participating in scientific congresses/meetings internationally to understand the role of emerging data on patient treatment within the TA covered, when requested, allowing for more balanced Scientific exchange.
Support the preparation of non-promotional Medical Education Programs by sharing data publication updates
Performing all company business in accordance with company policies and procedures and country regulations
Cost Centre Management
Obtain manager approval for all travel and extraneous expenditure
Manage cost of local/international travel within the company travel policy
Clear and concise communication skills (verbal, written, presentations) and interpersonal skills with the ability to work in cross-func
Benefits
Health insuranceVision insuranceFlexible schedule
Additional Information
Job Description
Senior Medical Scientific Liaison
Join a Global Innovative Pharmaceutical Company
Supportive and flexible team culture
Great opportunity for Personal and Professional development
Our Medical Affairs team advances patient care by engaging in scientific exchange with external medical experts and industry leaders ensuring the scientific value of our products is understood. We connect, communicate and train internal employees to ensure a thorough understanding of the science behind the medicine and review further unmet medical needs to support collaboration to further differentiate our portfolio.